CLINICAL_TRIALS
trial_result
· 2020-09-28
Clinical Trial Update: Phase IIb Study of Evobrutinib in Subjects With Rheumatoid Arthritis [Phase 2]
Summary
Phase IIb trial of evobrutinib in rheumatoid arthritis completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2020-09-28